Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000242

Type of data
NGS (Target Capture)
Access criteria
Controlled-access (Type I)
Total data volume
4.4 TB
File formats
  • FASTQ
Research
hum0157
Date published
2020-09-28
Date modified
2020-11-18
DDBJ Search
JGAD000242 (opens in a new tab)
JGA Study
JGAS000164 (opens in a new tab)

Analysis method

Targeted DNA sequencing

Materials and participants
cancer: 183 cases
(tumor tissues [FFPE sample] and normal blood cells)
lung cancer (ICD10: C34): 53 cases
soft tissue sarcoma (ICD10: C40-41): 39 cases
colon cancer (ICD10: C17-20): 24 cases
endometrial cancer (ICD10: C54): 15 cases
ovarian cancer (ICD10: C56): 12 cases
endometrial sarcoma (ICD10: C54): 8 cases
hypopharyngeal cancer (ICD10: C13): 4 cases
adenoid cystic carcinoma (ICD10: C07-08): 4 cases
cancer of unknown primary (ICD10: D48): 5 cases
other types of cancer: 19 cases
  • Health status
    Affected
  • Subject count
    183 (Individual)
Disease
  • lung cancer
  • soft tissue sarcoma
  • colon cancer
  • endometrial cancer
  • ovarian cancer
  • endometrial sarcoma
  • hypopharyngeal cancer
  • adenoid cystic carcinoma
  • cancer of unknown primary
Sample description
DNAs extracted from tumor tissues and peripheral blood cells
  • Tissue
    Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
Targeted DNA sequencing
Target
DNA panel: 464 genes
RNA panel: 449 genes
genes are listed in supplementary table 1
Reagent kit
SureSelect Custom
Fragmentation
Enzymatic fragmentation (Kapa Biosystems)
Platform
Illumina NextSeq
Read type
Paired-end
Read length
151 bp
Data use policy
NBDC data sharing policy (JGAP000001)